Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Cell Reports. Medicine|January 27, 2024
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virusRobert W Cross, Karla A Fenton, Courtney Woolsey, et al.
Nature Medicine|January 13, 2025
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primatesRobert W Cross, Courtney Woolsey, Abhishek N Prasad, et al.
Journal of Virology|January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Structural & Molecular Biology|April 30, 2021
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteinsHa V Dang, Robert W Cross, Viktoriya Borisevich, et al.
Nature Communications|March 26, 2021
Combination therapy protects macaques against advanced Marburg virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Vaccines|November 27, 2021
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-ParticleJoshua M Royal, Carrie A Simpson, Alison A McCormick, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2023
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virusRobert W Cross, Megan L Heinrich, Karla A Fenton, et al.
Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.
Science Advances|March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infectionCourtney Woolsey, Robert W Cross, Victor C Chu, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Cell Reports. Medicine|January 27, 2024
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virusRobert W Cross, Karla A Fenton, Courtney Woolsey, et al.
Nature Medicine|January 13, 2025
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primatesRobert W Cross, Courtney Woolsey, Abhishek N Prasad, et al.
Journal of Virology|January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Structural & Molecular Biology|April 30, 2021
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteinsHa V Dang, Robert W Cross, Viktoriya Borisevich, et al.
Nature Communications|March 26, 2021
Combination therapy protects macaques against advanced Marburg virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Vaccines|November 27, 2021
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-ParticleJoshua M Royal, Carrie A Simpson, Alison A McCormick, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2023
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virusRobert W Cross, Megan L Heinrich, Karla A Fenton, et al.
Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.
Science Advances|March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infectionCourtney Woolsey, Robert W Cross, Victor C Chu, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Pageof 13